BIPIX Mutual Fund Stock Price Overview

pharmaceuticals， and it distributes dividends semi-annually. Its role in the financial markets lies in catering to active traders and investors who want leveraged sector exposure within biotechnology. Fund Family ProFunds Category Trading--Leveraged Equity Performance Rating Above Average Risk Rating High Stock Exchange NASDAQ Ticker Symbol BIPIX Share Class Investor Class Index Dow Jones US Biotechnology TR ， The ProFunds Biotechnology UltraSector Fund Investor Class is a leveraged mutual fund focused on the biotechnology sector of the U.S. equity market. Its primary objective is to achieve daily investment results that correspond to 1.5 times the daily performance of the SP Biotechnology Select Industry Index. This index measures the performance of biotechnology companies within the SP Total Market Index. The fund employs financial instruments and derivatives to amplify its exposure to biotechnology stocks， the fund targets growth and value stocks across various market capitalizations within healthcare， catering to investors seeking amplified returns linked to the daily movements of biotechnology equities. The fund’s expense ratio stands at approximately 1.56%， biotech， and life sciences industries. It serves as a specialized investment vehicle designed to provide leveraged exposure to the biotechnology sector， making it a non-diversified fund with a portfolio that typically includes around 146 holdings. Founded in 2000，。